Učitavanje...
Myeloid Mineralocorticoid Receptor Activation Contributes to Progressive Kidney Disease
Clinical and experimental studies have shown that mineralocorticoid receptor (MR) antagonists substantially reduce kidney injury. However, the specific cellular targets and mechanisms by which MR antagonists protect against kidney injury must be identified. We used conditional gene deletion of MR si...
Spremljeno u:
| Glavni autori: | , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Nephrology
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4178428/ https://ncbi.nlm.nih.gov/pubmed/24700867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2012111094 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|